3316
K. Ryan et al. / Tetrahedron 56 (2000) 3309±3318
dd, 4H), 3.95 (m, 2H), 3.90 (m, 2H), 3.83 (br dd, 4H), 3.59
(q, 4H), 3.46 (m 2H), 3.08 (br dd, 4H), 3.02 (m, 2H), 2.58
(m, 4H), 2.30 (br m, 4H), 1.54 (br s, 6H), 1.20 (t1m, 16H),
0.75 (dd, 2H), 20.12 (s, 9H); FAB-HRMS, calcd for
C74H93N13O12S 1383.6836, found 1383.6884.
(3S,4S)-N-Boc-3,4-diazidopyrrolidine (21). To a solution
of (3R,4R)-N-Boc-pyrrolidinediol dimesylate 20 (8.60 g,
23.93 mmol) in DMF (200 ml) was added NaN3 (16.8 g,
0.258 mol). The mixture was heated to 908C for 24 h, then
evaporated to dryness in vacuo. The residue was diluted
with EtOAc (100 ml) and washed with water (3£20 ml).
The aqueous portion was back-extracted with EtOAc
(1£20 ml). The organic portions were combined, washed
with brine (1£10 ml), dried (MgSO4) and concentrated.
The residue was ®ltered through a plug of silica gel (20%
EtOAc/hexanes) and concentrated to give 21 as a yellow oil
(4.12 g, 68%). TLC Rf0.81 (25% EtOAc/hexanes); IR
Deprotected one-arm receptor (19). Tri¯uoroacetic acid
(TFA, 0.2 ml) was added to a stirred suspension of 2 in
DCM (2 ml). The reaction was followed by TLC (solvent
system A, Rf0.45). After 15 h the solvent (and excess
TFA) was evaporated under reduced pressure to yield a
dark red solid, 19, TFA salt (134 mg, 95 %): IR (KBr):
nmax 3286, 2934, 2861, 1654, 1612, 1552, 1510, 1437,
1
(®lm) nmax 2970, 2097, 1695 cm21; H NMR (400 MHz,
1395, 1339 cm21
;
1H NMR (400 MHz, DMSO-d6) d
CDCl3) d 3.94 (m, 2H), 3.65 (m, 2H), 3.34 (m, 2H), 1.45
(s, 9H); LRMS (CI) Calcd for C9H15N7O2 253.26, found
254.
[ppm] 8.78 (br m, 2H), 8.35 (d, 4H), 7.91 (d, 4H), 7.85 (d,
4H), 7.70 (dd, 2H), 7.05 (d, 4H), 6.95 (d, 4H), 6.82 (d, 4H),
4.22 (dd, 4H), 4.09 (m, 2H), 3.86 (m, 4H), 3.59 (q, 4H), 3.38
(br m, 2H), 3.09 (m, 4H), 2.82 (br m, 2H), 2.55 (m, 4H), 2.29
(br m, 4H), 1.68 (br d, 6H), 1.18 (t1m, 16H); FAB-LRMS,
calcd for C68H81N13O10 (free base) 1240.5, found 1242.
(3S,4S)-3,4-Diazidopyrrolidine, TFA salt (22). To a stir-
red solution of 21 (1.00 g, 3.95 mmol) in DCM (25 ml) was
added tri¯uoroacetic acid (2.5 ml). After TLC indicated
complete conversion, the solvent and excess TFA were
removed in vacuo, to yield 21 (1.05 g, quant.), which was
used without further puri®cation. TLC Rf0.4 (10% MeOH/
General sulfonamide coupling procedure (e.g. 5 and 9).
To a stirred solution of 19 (12.3 mg, 9 mmol) in N-methyl-
pyrrolidinone (NMP, 0.4 ml) was added DIEA (5 ml,
27 mmol), followed by naphthyl-2,7-disulfonyl chloride
(1.5 mg, 4.5 mmol) in NMP (20 ml). The reaction was
followed by TLC (solvent system A). After 9 h, additional
disulfonyl chloride was added (0.49 mg, 0.3 mmol, in 11 ml
DMF). After stirring for a total of 45 h, enough silica gel to
absorb all the reaction solvent was added. The entire reac-
tion mixture was transferred to the top of a chloroform/silica
gel ¯ash chromatography column. The products were eluted
with a 0±5% MeOH gradient in chloroform. (Note: The
poor solubility of 19 and the products necessitated the
use of the polar, high-boiling solvent NMP. In some cases
the NMP co-eluted with the puri®ed product and could not
be removed, e.g. 5. The sulfonyl chlorides also slowly
decomposed in this solvent.)
1
DCM); H NMR (400 MHz, DMSO-d6) d 9.43 (br s, 2H),
4.53 (dd, 2H), 3.39 (dd, 2H), 3.23 (dt, 2H).
Disperse red-pyrrolidine diazide (23). To a solution of
disperse red (300 mg, 0.95 mmol) in THF (15 ml) was
added 1,10-carbonyldiimidazole (189 mg, 1.15 mmol).
After 6 h a solution of 22 (TFA salt, 400 mg, 1.50 mmol)
and diisopropylethylamine (0.30 ml, 1.72 mmol) in THF
(2 ml) was added. The mixture was brought to re¯ux over-
night. The crude mixture was evaporated to dryness in
vacuo and puri®ed by silica gel chromatography (40%
EtOAc/hexanes) to give 23 as a red powder (461 mg,
0.934 mmol, 98%]. TLC Rf0.13 (25% EtOAc/hexanes);
IR (KBr) nmax 2100, 1694, 1604, 1516, 1427, 1390, 1338,
1142, 1106 cm21; 1H NMR (400 MHz, DMSO-d6) d 8.34 (d,
2H), 7.91 (d, 2H), 7.83 (d, 2H), 6.91 (d, 2H), 4.30 (m, 2H),
4.21 (t, 2H), 3.71 (t, 2H), 3.50 (m, 4H), 3.24 (m, 2H), 1.15 (t,
3H); LRMS (CI) calcd for C21H23N11O4 493.48, found 494.
Receptor (5): 2.2 mg (including an unknown amount of
NMP) Rf0.6 (10% MeOH/chloroform); FAB-LRMS,
calcd for C146H166N26O24S2 2733.2, found 2734.
Receptor (9): 5.5 mg (81%), Rf0.1 (10% MeOH/chloro-
form); FAB-LRMS, calcd for C78H87N13O15S2 1510.74,
found, 1512.
Receptor (6): 5.0 mg (51%), Rf0.74 (10% MeOH/
DCM); MALDI-TOF MS, calcd for C142H164N26O24S2
2683.11, found 2706.99 (M1Na).
Receptor (10): 2.1 mg (38%), Rf0.4 (10% MeOH/
DCM); MALDI-TOF MS, calcd for C74H85N13O15S2
1459.57, found 1497.67 (M1K).
Receptor (7): 5.4 mg (including an unknown amount of
NMP) Rf0.75 (eluted ®rst in 5% MeOH/chloroform
then in solvent system A: FAB-LRMS, calcd for
C142H164N26O24S2 2683.1, found 2684.
Disperse red-pyrrolidine diamine (24). A solution of 23
(40 mg, 0.08 mmol) and triphenylphosphine (50 mg,
0.19 mmol) in toluene (1.5 ml) was brought to re¯ux.
After 10 min, the reaction mixture was cooled to 508C,
and a solution of water (0.025 ml) in THF (0.3 ml) was
added. Re¯ux was resumed and continued overnight.
After evaporation of the solvents the crude product was
puri®ed by ¯ash chromatography (1% Et3N/10% MeOH/
DCM) to yield a red solid (34 mg, 0.077 mmol, 95%).
TLC Rf0.29 (1% Et3N/10% MeOH/DCM); IR (KBr)
nmax 1509, 1438, 1193, 1120, 858, 785, 722, 695,
1
651 cm21; H NMR (400 MHz, DMSO-d6) d 8.35 (d, 2H),
7.93 (d, 2H), 7.84 (d, 2H), 6.93 (d, 2H), 4.17 (t, 2H), 3.70 (t,
2H), 3.52 (m, 4H), 2.93 (m, 4H), 1.16 (t, 3H); LRMS (CI)
calcd for C21H27N7O4 441.48, found 442.
Receptor (11): 6.2 mg (67%): Rf0.35 (eluted as in 7);
FAB-HRMS, calcd for C74H86N13O15S2 (M11)
1460.5808, found 1460.5769.
(1R,2R)-Cyclohexanedicarboxylic acid mono-n-propyl-
amide (25). To a stirred solution of 12 (150 mg, 0.97
mmol) in DCM (10 ml) was added dropwise n-propylamine
(0.25 ml, 3.02 mmol). A white precipitate soon appeared
and the reaction mixture was stirred for 2 h, followed by
Receptor (8). Made similarly, but the dipenta¯uorophenol
ester of benzene-1,3-dicarboxylic acid was used in place
of the aromatic disulfonyl chlorides. 8.7 mg (90 %):
FAB-LRMS, calcd for C144H164N26O22 2611.0, found
2612.